000			02283 a2200613 4500
005			20250517185553.0
264		0	_c20180731
008			201807s 0 0 eng d
022			_a1873-2518
024	7		_a10.1016/j.vaccine.2017.11.034 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeung, Ting Fan
245	0	0	_aComparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. _h[electronic resource]
260			_bVaccine _c01 2018
300			_a98-106 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdolescent
650	0	4	_aAluminum Hydroxide _xadministration & dosage
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aAntibody Formation _ximmunology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aChild
650	0	4	_aCohort Studies
650	0	4	_aFemale
650	0	4	_aHuman papillomavirus 16 _xgenetics
650	0	4	_aHuman papillomavirus 18 _xgenetics
650	0	4	_aHumans
650	0	4	_aImmunity, Cellular
650	0	4	_aImmunization _xmethods
650	0	4	_aImmunization Schedule
650	0	4	_aImmunogenicity, Vaccine
650	0	4	_aNeutralization Tests
650	0	4	_aPapillomaviridae _ximmunology
650	0	4	_aPapillomavirus Infections _xprevention & control
650	0	4	_aPapillomavirus Vaccines _xadministration & dosage
700	1		_aLiu, Anthony Pak-Yin
700	1		_aLim, Fong Seng
700	1		_aThollot, Franck
700	1		_aOh, Helen May Lin
700	1		_aLee, Bee Wah
700	1		_aRombo, Lars
700	1		_aTan, Ngiap Chuan
700	1		_aRouzier, Roman
700	1		_aDe Simoni, Stéphanie
700	1		_aSuryakiran, Pemmaraju
700	1		_aHezareh, Marjan
700	1		_aThomas, Florence
700	1		_aFolschweiller, Nicolas
700	1		_aStruyf, Frank
773	0		_tVaccine _gvol. 36 _gno. 1 _gp. 98-106
856	4	0	_uhttps://doi.org/10.1016/j.vaccine.2017.11.034 _zAvailable from publisher's website
999			_c27823824 _d27823824